AN2 Therapeutics Inc (ANTX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | ||||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -10.33M | -11.77M | -12.48M | -16.04M | -16.6M | -18.18M | -18.82M | -18.3M |
| Pre Tax Income | -10.12M | -11.34M | -11.84M | -15.32M | -15.8M | -16.71M | -16.9M | -16.62M |
| Net Income | -10.12M | -11.34M | -11.84M | -15.32M | -15.8M | -16.71M | -16.9M | -16.62M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -10.35M | -11.81M | -12.47M | -15.32M | -15.8M | -16.71M | -16.9M | -16.62M |
| EBITDA | -10.33M | -11.77M | -12.48M | -16.04M | -16.6M | -18.18M | -18.82M | -18.3M |
| Year End December 30 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -21.61M | -42.26M | -69.64M |
| Pre Tax Income | -21.54M | -40.96M | -64.73M |
| Net Income | -28.06M | -42.78M | -64.73M |
| Preferred Dividends | -6.52M | -1.82M | 0 |
| Basic Earnings Per Share (EPS) | -0.005 | -2.205 | -2.177 |
| EBIT | -21.61M | -42.31M | -64.73M |
| EBITDA | -21.61M | -42.26M | -69.64M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
